Meropenem/voriconazole Reactions 1680, p219 - 2 Dec 2017 Increased voriconazole level: case report A 78-year old man had an increased level of voriconazole following meropenem and voriconazole interaction. The man, who was newly diagnosed with high risk prostate cancer, was hospitalised for open prostatectomy and his postoperative course was complicated by right heart failure, intra-abdominal haematoma and ischemia of large parts of the colon requiring subtotal colectomy and ileostomy, progressive renal impairment requiring dialysis and multiple bacterial and fungal infections including bacteremia with multidrug- resistant Klebsiella pneumoniae, systemic fungal infection with Candida glabrata, infections with Enterococcus faecium, Pseudomonas aeruginosa and Aspergillus fumigatus. He received treatment with IV voriconazole, meropenem and their combination [route and dosage not stated] at numerous times, for multiple infections. His voriconazole concentration was noted using a high-performance liquid chromatography assay throughout the anti fungal treatment phases, which showed that voriconazole dose requirements rapidly and substantially decreased to approximately one third whenever meropenem was co-administered. These findings indicated that meropenem considerably impairs voriconazole clearance. As he had not received any cytochrome P450 (CYP) mediated co-medications which are known to interact with voriconazole and meropenem therapy, a novel drug interaction between voriconazole and meropenem was suspected. He received various co-medications and none of the drug had interfered with CYP isoenzymes. From the in vitro and in vivo studies it was concluded that the metabolic ratio of voriconazole decreased whenever co-administered with meropenem and quickly recovered upon discontinuation of meropenem, which suggested impairment of voriconazole metabolism by meropenem. Author comment: "We repeatedly observed a substantial concentration-dependent interaction between meropenem and voriconazole in a patient on high-dose meropenem and in vitro confirmed the suspected inhibitor action of meropenem on CYP3A4 and CYP2C19, the key enzymes involved in voriconazole metabolism." Mahmoudi M, et al. Substantial impairment of voriconazole clearance by high-dose meropenem in a patient with renal failure. Clinical Infectious Diseases 65: 1033-1036, No. 6, 15 Sep 2017. Available from: URL: cix443 - Germany 803284125 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial